India to review COVID-19 vaccines after blood clot warning - report

A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in India, financial daily Mint reported on Friday, citing two people aware of the development. India is currently administering AstraZeneca's COVID-19 vaccine, which is manufactured by the Serum Institute and branded Covishield, and a shot developed by Bharat Biotech called COVAXIN.

Reuters | Updated: 09-04-2021 08:09 IST | Created: 09-04-2021 08:09 IST
India to review COVID-19 vaccines after blood clot warning - report

A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in India, financial daily Mint reported on Friday, citing two people aware of the development.

India is currently administering AstraZeneca's COVID-19 vaccine, which is manufactured by the Serum Institute and branded Covishield, and a shot developed by Bharat Biotech called COVAXIN. The review comes after Europe's drug regulator said on Wednesday it found a possible link between AstraZeneca's vaccine and rare blood clotting issues in adults who had received the shot, although it added the vaccine's advantages still outweighed the risks.

India is banking on vaccinations to help contain a record surge in cases in its second wave. The country reported a massive 126,789 new COVID-19 cases on Thursday. "We are looking at side-effects of blood clots that have been seen in people who received Covishield and Covaxin, even if it was a mild case," a source told Mint, who added that a report on it was likely to be ready by next week. (https://bit.ly/2OAP4wc)

Following Europe's announcement, several countries have announced restrictions on the use of the AstraZeneca vaccine in younger people.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

100-meter champ Coleman to miss Olympics despite reduced ban

The fastest man in the world, American sprinter Christian Coleman, will miss the Tokyo Olympics after failing Friday in an appeal to overturn his ban for missed doping tests.The Court of Arbitration for Sport CAS did cut the 100-meter world...

COVID-19: Lockdown in all UP districts on Sunday

Amid a surge in COVID-19 cases, the Uttar Pradesh government has announced a lockdown across the state on Sunday.To enforce wearing of masks, the state government has doubled the fine to Rs 1000 for those caught without masks for the first ...

WHO chief says COVID-19 infection rate approaching highest of pandemic so far

The number of new COVID-19 cases per week has nearly doubled globally over the past two months, approaching the highest rate seen so far during the pandemic, the head of the World Health Organization said on Friday.Cases and deaths are cont...

Hindi writer Shivani's 'Amader Shantiniketan' English translation to be out in May

The English translation of the late Hindi writer Shivanis memoir Amader Shantiniketan will hit the stands in May, Penguin Random House India PRHI announced on Friday.The book, translated by the authors daughter Ira Pande, will be published ...

Give Feedback